Email a Friend
Printer Friendly
Slashdot It!
Submit to Reddit
Add to Facebook

Scientists show how molecular switch helps pancreatic cancer beat drugs

January 29, 2010

Researchers at the Moores Cancer Center at the University of California, San Diego, have found one reason that pancreatic cancer tumors are so difficult to treat with drugs. They have shown how a molecular switch steps up pancreatic cancer cell survival as well as resistance to a standard chemotherapy drug, and have identified alternate routes cancer cells take to avoid the effects of the therapy.

The findings, by a group led by Andrew M. Lowy, MD, professor of surgery and chief of surgical oncology at the UCSD School of Medicine and the Moores UCSD Cancer Center, are reported online and will appear February 1 in the journal Cancer Research. The study provides new insights into pancreatic cancer development and new potential drug targets and treatment strategies against the disease.

"To understand how to treat pancreatic cancer tumors, we need to better understand their circuitry and behavior," Lowy said.

Pancreatic cancer is a particularly deadly cancer, fast-moving and difficult to detect early. It's estimated that more than 35,000 people died from pancreatic cancer last year in the United States.

RON is a signaling protein known as a tyrosine kinase, essentially a switch that turns on various activities in cells. Previous work in Lowy's lab showed that RON is overexpressed in a majority of precancerous and pancreatic cancer cells, and could also help cells resist dying. The researchers wanted to find out what role, if any, RON played in pancreatic cancer development and progression.

In a series of experiments, the researchers showed that RON sends signals that regulate the activity of genes that help tumors cells survive, "implying RON is a potent survival signal for pancreatic cancer cells," Lowy said.

To see the effects of reducing or blocking RON activity, the team shut down RON expression in pancreatic cancer cells using a molecular technique called "gene silencing," and then used those cells to establish tumors in mice. Those tumors were treated with gemcitabine, the most common chemotherapy drug used to treat pancreatic cancer patients. Tumors in which RON was silenced were much more sensitive to the chemotherapy than the RON-expressing cancer cells.

"This is the first demonstration that RON-directed therapy in an animal model can sensitize tumors to chemotherapy," Lowy said. Yet, the scientists found that the cancer cells and tumors were eventually able to bypass the silencing agent as well as the drug's effects, and continued to grow.

About 50 percent of the tumor cells re-expressed RON. The researchers also found that the tumor cells activated other growth proteins, including epidermal growth factor receptor (EGFR), to enable them to continue to grow.

"This is what most tumors do," Lowy said, explaining that clinically, pancreatic cancer tumors often respond to therapy at first, only to begin growing again. "We know that diseases such as pancreatic cancer are too complex for one drug to be effective. If we can learn to predict the results of RON-directed therapy, maybe we can combine it with an EGFR-directed therapy, for example, to take away tumor escape routes."

Lowy explained that scientists still need far more information about RON's part in pancreatic cancer development and progression. "We need to figure out which tumors are relying on RON," he said. "If we could develop biomarkers to identify which tumors are going to be susceptible to RON-targeted therapy, then we can begin to figure out what tumors do to escape such treatments."

University of California - San Diego

Related Pancreatic Cancer Current Events and Pancreatic Cancer News Articles

Pancreatic Cancer Current Events and Pancreatic Cancer News RSS

UNC Lineberger scientists identify molecular predictor of prognosis for pancreatic cancer patients
Pancreatic cancer is one of the most challenging tumors to treat. Identifying patients who have more aggressive disease could better inform treatment decisions and predict survival prognosis. A new finding from scientists at UNC Lineberger Comprehensive Cancer Center may help.

Researchers use nanoparticles to shrink tumors in mice
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.

ESMO publishes updated guidelines on cancer care
The European Society for Medical Oncology (ESMO) just released an enhanced and revised set of clinical recommendations designed to help oncologists deliver the best quality care to their patients.

Endoscopic ultrasound evaluation is associated with improved outcomes in pancreatic cancer patients
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery.

TGen finds protein inhibitor revives chemotherapy for ovarian patients
Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy.

New combination effective against pancreatic cancer
The new cancer medication sorafenib looks promising. Sorafenib is used for advanced liver and kidney cancer and also appears to be effective against cancer stem cells in pancreatic cancer. The team led by Professor Dr. Ingrid Herr, Head of the Department of Molecular Oncosurgery, a group of the Department of Surgery at Heidelberg University Hospital, (Managing Director: Professor Dr. Markus W. Büchler) in cooperation with the German Cancer Research Center, tested the new substance in mice and pancreatic cancer cells.

Cysts Hold Clues to Pancreatic Cancer
Working with researchers from the University of Michigan and Indiana University, Van Andel Research Institute (VARI) investigators have developed a method that could be used to predict whether pancreatic cysts are benign or are precursors to invasive cancer.

Targeted Immunotherapy Shows Promise in Penn Medicine Studies for Metastatic Breast and Pancreatic Cancers
Early trials using targeted monoclonal antibodies in combination with existing therapies show promise in treating pancreatic cancer and metastatic breast cancer, according to research that will be presented by investigators from the University of Pennsylvania's Abramson Cancer Center at the 2010 meeting of the American Society of Clinical Oncology June 4 through 8.

Circulating tumor cells correlate with poorer survival in pancreatic cancer patients
Fox Chase Cancer Center investigators find that pancreatic cancer patients who have circulating tumor cells tend to have worse outcomes than patients without circulating tumor cells. Additionally, the team has uncovered evidence that not all circulating tumor cells are the same, and some may predict worse outcomes than others.

Response to preoperative therapy may predict survival in pancreatic cancer patients
Cancer of the pancreas--a glandular organ that lies behind the stomach and secretes vital enzymes and hormones--seldom is detected in early stages, making treatment difficult and survival statistics particularly grim.

More Pancreatic Cancer Current Events and Pancreatic Cancer News Articles

	100 Questions & Answers About Pancreatic Cancer, Second Edition by Eileen O'Reilly (Author), Joanne Frankel Kelvin (Author) Whether you re a newly diagnosed pancreatic cancer patient, a survivor, or a friend or relative of someone with pancreatic cancer, this book offers help. The only text to provide a doctor s and patient s view, 100 Questions & Answers About Pancreatic Cancer, Second Edition gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. The authors, a medical oncologist and a nurse with 25 years of experience with cancer patients, provide a comprehensive, step-by-step discussion of what you can expect in the diagnosis and treatment of pancreatic cancer, while patient commentaries provide a real-life understanding of what these steps might mean for your day-to-day life. This book is an invaluable...
	Pancreatic Cancer (M.D. Anderson Solid Tumor Oncology Series) by Andrew M. Lowy (Editor), Steven D. Leach (Editor), Philip Philip (Editor) Since the previous M.D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical trials in both resectable and metastatic pancreatic cancer have been completed, raising new questions about the standard of care in this disease. Finally, the era of targeted biologic therapies has engendered new excitement about the prospects of more rapid progress in understanding and successfully treating this dreadful disease. Therefore, it is an appropriate time to review these important...
	Pancreatic Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages. Everything You Need to Know About Pancreatic Cancer. Pancreatic Cancer: This book is for people who have pancreatic cancer (cancer of the pancreas), as well as for their family members, friends, students, and others who want to find out more about this disease. It will also give you pancreatic cancer signs and what to look for. This National Cancer Institute (NCI) booklet has important information about cancer of the pancreas. In the United States, cancer of the pancreas is diagnosed in more than 29,000 people every year. It is the fifth leading cause of cancer death. This booklet discusses possible causes of cancer of the pancreas. It also describes symptoms, diagnosis, treatment, and followup care. This information can help patients and their families better understand and cope with this disease. Scientists are studying...
	Sterling Silver Amethyst & Diamond Accent Pancreatic Cancer Awareness Ribbon Pendant by SilverSpeck.com Show your support for the fight against Pancreatic Cancer with our genuine amethyst Purple Ribbon pendant. The pendant features graduating round amethyst stones and one single genuine diamond. The Purple ribbon is a symbol to share hope, strength, courage and show that you care. The pendant dangles from an 18-inch rolo chain and is crafted of tarnish resistant sterling silver.
	100 Q&A About Pancreatic Cancer (100 Questions & Answers) by Joanne Frankel Kelvin Eileen O'Reilly (Author) EMPOWER YOURSELF! Whether you’re a newly diagnosed pancreatic cancer patient, a survivor, or a friend or relative of someone with pancreatic cancer, this book offers help. The only text to provide a doctor’s and patient’s view, 100 Questions & Answers About Pancreatic Cancer gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. The authors, a medical oncologist and a nurse with 25 years of experience with cancer patients, provide a comprehensive, step-by-step discussion of what you can expect in the diagnosis and treatment of pancreatic cancer, while patient commentaries provide a real-life understanding of what these steps might mean for your day-to-day life. This book is an...
	Neuroendocrine Tumors (Home Use) Part of the award winning public television series Healthy Body/Healthy Mind. Neuroendocrine tumors are a group of cancers that can originate from neuroendocrine cells throughout the body. In this program we take a look at this mysterious form of cancer and the astonishing success scientists have had recently. With the latest advancements in research doctors have been able treat these tumors and increase the 5 year survival rate by 50 percent. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply.
	Pancreatic Cancer: Current and Emerging Trends in Detection and Treatment (Cancer and Modern Science) by Amy Sterling Casil (Author)
	Beating Pancreatic Cancer Together T-shirt Large White by Shop Zeus
	Cancer Be Gone Guided imagery CD taps into the immense power of the mind to enhance comfort, healing, an optimistic attitude and positive expectations. Metaphor of "cancer as weeds in a garden that are easily managed".
	Pancreatic Cancer Awareness Ribbon Business Card Holder by MyHeritageWear.com The Pancreatic Cancer Ribbon proudly displayed on a business card holder. There is no better way to achieve remembrance and awareness for the meaning of the Pancreatic Cancer Ribbon than to display it on your business card holder for everyone to see. This sleek and modern card case is perfect to store business cards and/or credit cards. The convenient pocket size business card holder cover features the Pancreatic Cancer Ribbon on a white background framed in executive stainless steel. The back of the cardholder is a professional and executive stainless steel. This business card holder makes a great gift anytime of the year for anyone who wants to increase awareness by showing the Pancreatic Cancer Ribbon.